SpaceX Crew-12 mission to send 4 astronauts to space station. Photos

SpaceX is scheduled to launch Crew-12 to the International Space Station aboard a Dragon spacecraft atop a Falcon 9 rocket from Cape Canaveral SLC-40 at 6:01 a.m. EST on Feb. 11, 2026. The four-person crew includes NASA commander Jessica Meir (her second ISS mission), NASA pilot Jack Hathaway (first flight, 2021 astronaut class), ESA mission specialist Sophie Adenot and Roscosmos cosmonaut Andrey Fedyaev, underscoring continued commercial crew operations and multinational cooperation; the report contains no financials and is unlikely to materially impact markets.

Analysis

Market structure: A successful Crew‑12 flight reinforces SpaceX’s commercial crew incumbency and keeps downward pressure on per‑launch pricing; incumbents who directly benefit are launch integrators, rideshare/LEO service providers and satellite constellations that depend on frequent, lower‑cost access. Losers are legacy crew transport vendors (Boeing’s Starliner/BA) and any small launchers that cannot match cadence; expect pricing pressure of 10–30% on marginal contract bids over 12–36 months. Cross‑asset effects are modest: positive risk appetite for small cap aerospace (XAR) and selective equities, negligible commodity impact; limited bond spread tightening for well‑rated primes (LMT, RTX).

Risk assessment: Tail risks include a Crew‑12 anomaly (grounding cascade), US‑Russia/ESA geopolitical frictions affecting multinational crews, and NASA budget reallocation; any anomaly could compress sector multiples by 5–15% for weeks. Immediate (days) market moves should be muted; short term (weeks–months) sentiment swings favor launch‑service beneficiaries; long term (years) structural advantage to high‑cadence providers. Hidden dependencies: supplier bottlenecks (engines, avionics), export controls and NASA contract timing. Key catalysts: upcoming NASA contract awards and Starliner test milestones in the next 30–90 days.

Trade implications: Favor relative longs to proven primes/ETF and tactical shorts on Boeing commercial exposure. Concrete plays: small-cap exposure to XAR or LMT for steady cashflows (12‑month target +10–15%), pair short BA vs long LMT over 3–12 months for 5–10% relative alpha. Use option structures to control downside: BA put spreads (3–6 month) sized <1% portfolio to hedge tail risk.

Contrarian angles: Consensus understates Boeing’s defense resaleability—BA could outperform if defense offsets commercial weakness; shorting BA outright is crowded and could be mean‑reverting. Also markets underprice the upside to suppliers of satellite ops/ground infrastructure as launch costs fall—look for 12–24 month winners in ground segment and data‑service providers. Historical parallel: post‑Shuttle era reallocation—incumbents survived by pivoting to defense/services, so emphasize diversified primes rather than pure commercial launch plays.

Key Decisions for Investors

• Establish a 2–3% portfolio long in SPDR S&P Aerospace & Defense ETF (XAR) or Lockheed Martin (LMT) to capture sustained NASA/DoD spending and higher launch cadence; 12‑month target +10–15%, stop‑loss at −8%.
• Implement a pair trade: short 1–1.5% of portfolio in Boeing (BA) and long 1–1.5% in LMT (or XAR) to capture expected commercial‑crew underperformance over 3–12 months; target 5–10% relative outperformance, tighten stops at 8% absolute moves.
• Buy a BA 3–6 month put spread (buy ~25‑delta put, sell ~10‑delta put) sized at 0.5–1.0% of portfolio to hedge downside risk from further Starliner setbacks or a launch anomaly; cost‑financed to limit drawdown.
• Allocate 1–2% to mid/small‑cap ground‑infrastructure and satellite service names (examples: Iridium/actual tickers per research) over 12–24 months to play secondary demand as launch pricing falls by 10–30%; reweight after NASA contract awards in next 30–90 days.